AHA Scientific Publishing Ethical Conduct Policy
- The AHA Scientific Publishing Ethical Conduct Policy (downloadable PDF) contains the full ethical conduct policy.
- All American Heart Association journals adhere to the American Heart Association ethical conduct policy as outlined in Miano J. What is Truth? Standards of Scientific Integrity in American Heart Association Journals. Arterioscler Thromb Vasc Biol. 30:1-4 (http://atvb.ahajournals.org/content/full/30/1/1). By submitting a manuscript for review by [the journal,] authors certify that they abide by the ethical policies and standard of scientific integrity required by the American Heart Association.
Prior Publication, Duplication Submissions, & Overlapping Work
Manuscripts are considered on the understanding that they contain original material, that the manuscript and material within the manuscript have not been published and are not being considered for publication elsewhere in whole or in part in any language, except as an abstract. The authors also certify that any and all other work in preparation, submitted, in press, or published that is potentially overlapping either in the actual data presented or in the conceptual approach is enclosed along with the original submission. Any material within the manuscript that has appeared elsewhere must be cross-referenced and permission to use or adapt the material must be received, in writing from the copyright holder.
Pre-Print Servers: Posting of un-refereed manuscripts to a community pre-print server by the author will not be considered prior publication, provided that the following conditions are met: 1) During submission, authors must acknowledge pre-print server deposition and provide any associated accession numbers or DOIs; 2) Versions of a manuscript that have been altered as a result of the peer review process may not be deposited; 3) The pre-print version cannot itself have been indexed in MEDLINE or PubMed; 4) Upon publication, authors are responsible for updating the archived pre-print with a DOI and link to the published version of the article.
- Abstracts/Webcasts: If some or all of the work in the manuscript has been published or submitted in abstract form, and/or overlapping data exists, the following rules apply: 1) The published or submitted abstract must accompany the submitted manuscript; 2) The abstract cannot itself have been referenced in MEDLINE or PubMed; 3) The potentially overlapping work and a separate explanation of the nature of any possible overlap with the submitted manuscript must accompany the submitted manuscript.
- These restrictions generally do not apply to presentations or press reports published in connection with scientific meetings, or to poster presentations at scientific meetings that are videotaped, provided that the material has not been widely circulated, copyrighted, or sold. Posting an audio recording, video recording, or short summary of a presentation made at a professional meeting on the Internet would be considered as a meeting presentation by the American Heart Association and would not compromise consideration of a submission. Direct release of information through press releases or media briefings may preclude publication.
- Articles published in Arteriosclerosis, Thrombosis, and Vascular Biology cannot be discussed with journalists or presented in other public media before 4:00 PM EST on the day before the cover date of the issue, except when articles are published online ahead of print (Online First). In such cases, the embargo date will be 4:00 PM EST on the day of online posting. Although the editorial office will endeavor to notify authors of the anticipated online publication date, neither the editorial office nor the AHA will be responsible for any consequences of early online posting with regard to intellectual property rights. To safeguard their intellectual property, authors should ensure that appropriate reports of invention and patent applications have been filed before the manuscript is accepted.
- Prior presentations at scientific meetings are allowed, but the authors should be aware that such presentations may undermine their intellectual property rights. Questions regarding the embargo policy should be directed to Cathy Lewis, Senior Manager, Consumer Health News, Corporate & Media Communications, AHA National Center, 7272 Greenville Avenue, Dallas, TX 75231-4596. Tel: 214-706-1324; fax: 214-369-3685; e-mail: firstname.lastname@example.org
Public Access Policy
- For Works created under grant and accepted for publication in an AHA journal, the author may cause the Accepted Version of the Work to be posted on the Web archive of a body that funded all or part of the Work, and/or an author's institutional repository, provided that this post appears no sooner than 6 months after the AHA publishes the Work in a journal and that the archive is publicly and noncommercially available via the World Wide Web.
- The "Accepted Version" means the paper includes peer review changes but not AHA's copyediting and production changes. "No sooner than 6 months after the AHA publishes the Work" means at least 6 months after the first appearance of the Work either on the AHA journal's Web site as a publish-ahead-of-print article or on the AHA journal's Web site published as part of a regular issue.
Instructions to Authors Main Menu
|Instructions for Authors Home||Manuscript Types|
|Manuscript Preparation||File Formatting|
|Submission Requirements||ATVB Awards|
|Research Guidelines||Journal Policies|
|Costs to Authors||Post Publication Policies|
|Useful Links||ATVB Home|